All the while, the obesity epidemic worsened: Between 1999 and 2017, the rate of obesity among American adults increased from 31% to 42%
GLP-1 is a peptide hormone that functions to augment the secretion of insulin in response to food and suppress the counter-regulatory hormone, glucagon
Zhang, H., Zhang, F
After an average follow-up of three years, Sheffeh and his team found that stroke survivor participants taking either a GLP-1 or SGLT2 medication had a 74% lower mortality risk and 84% lower risk of having a heart attack, compared to those not taking these drugs
Originally developed for type 2 diabetes, these drugs have become one of the most prescribed medication classes in the United States, driven by their effectiveness for blood sugar control, weight loss, and cardiovascular protection
Nausea is the most common side effect , reported by approximately 20% of patients in clinical trials